Concepedia

Katie Tuckwell

KT

22

Publications

2.6K

Citations

17

H-Index

2015

Active since

Affiliations

Roche (United Kingdom)(Current)

Massachusetts General Hospital

Harvard University

Stanford University

Universitat de Barcelona

Katie Tuckwell is an author at Roche (United Kingdom) specializing in medicine, vasculitis, and rheumatoid arthritis.

Top concepts

Publications per year

2015–2021

22

Publications

22

Trial of Tocilizumab in Giant-Cell Arteritis

John H. Stone, Katie Tuckwell, Sophie Dimonaco et al. · New England Journal of Medicine · 2017 · 1.3K citations · Full text

Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis

Cem Gabay, Iain B. McInnes, Arthur Kavanaugh et al. · Annals of the Rheumatic Diseases · 2015 · 148 citations · Full text

Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case–control analysis

Jessica C. Wilson, Khaled Sarsour, Neil Collinson et al. · Seminars in Arthritis and Rheumatism · 2016 · 128 citations

, , +5

Efficacy, Safety, and Pharmacodynamic Effects of the Bruton’s Tyrosine Kinase Inhibitor Fenebrutinib (GDC‐0853) in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial

David Isenberg, Richard Furie, Nicholas S. Jones et al. · Arthritis & Rheumatology · 2021 · 126 citations

Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial

Iván O. Rosas, George Diaz, Robert Gottlieb et al. · Intensive Care Medicine · 2021 · 124 citations · Full text

Rows per page

1–5 of 22